Prognostic factors in cytokine-refractory renal cell carcinoma treated with irinotecan, Cisplatin, and mitomycin chemotherapy

J Clin Oncol. 2005 Feb 20;23(6):1323-5. doi: 10.1200/JCO.2005.05.107.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / mortality
  • Cisplatin / administration & dosage
  • Cytokines / therapeutic use
  • Drug Resistance, Neoplasm
  • Humans
  • Irinotecan
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / mortality
  • Mitomycin / administration & dosage
  • Neoplasm Metastasis
  • Prognosis

Substances

  • Cytokines
  • Mitomycin
  • Irinotecan
  • Cisplatin
  • Camptothecin